Literature DB >> 2704786

Life shortening in mice exposed to fission neutrons and gamma rays. VIII. Exposures to continuous gamma radiation.

J F Thomson1, D Grahn.   

Abstract

Data are presented on the mean aftersurvival of male B6CF1 mice exposed for 22 h per day, 5 days per week, to 60Co gamma radiation at dose rates of 1.36 to 12.64 x 10(-3) cGy/min for 23 weeks or 1.36 to 6.32 x 10(-3) cGy/min for 59 weeks. For deaths from all causes, linear dose-response curves were obtained with slopes (days of life lost/cGy) of 0.158 +/- 0.016 and 0.077 +/- 0.002 for 23- and 59-week exposures, respectively. These values were not significantly altered when the analysis was restricted to those mice dying with tumors (92% of the total) or to those presumably dying from tumors (82% of the total). Analysis of mortality rates showed that about 90% of the radiation-specific excess mortality was tumor related. The 59-week exposure series induced only a small increase in the number of days of life lost/cGy/weekly fraction over that induced by 23 weeks of irradiation, 4.53 +/- 0.15 compared to 3.64 +/- 0.36 days lost/cGy/weekly fraction. This lower than expected value for 59 weeks of exposure may signal the approach to the final linear, additive, injury term postulated from earlier studies at this laboratory with low-dose-rate, daily, duration-of-life 60Co gamma irradiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704786

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

1.  Past and future work on radiobiology mega-studies: a case study at Argonne National Laboratory.

Authors:  Benjamin Haley; Qiong Wang; Beau Wanzer; Stefan Vogt; Lydia Finney; Ping Liu Yang; Tatjana Paunesku; Gayle Woloschak
Journal:  Health Phys       Date:  2011-06       Impact factor: 1.316

2.  Low-Dose-Rate Irradiation for 1 Hour Induces Protection Against Lethal Radiation Doses but Does Not Affect Life Span of DBA/2 Mice.

Authors:  Nina Frederike Jeppesen Edin; Čestmír Altaner; Veronika Altanerova; Peter Ebbesen; Erik O Pettersen
Journal:  Dose Response       Date:  2016-11-06       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.